[SYRE] YoY Quarter Result on 31-Mar-2024 [#Q1]

Stock
[SYRE] Spyre Therapeutics, Inc.
Announcement Date
09-May-2024
Financial Year
2024
Quarter
31-Mar-2024 [#Q1]
Profit Trend
QoQ- 30.58%
YoY- -138.07%
Quarter Report
SYRE's Result
SYRE's Financial Summary
View:
Show?
Quarter Result
31/03/24 31/03/23 31/03/22 CAGR
Revenue 0 198 1,362 -
PBT -43,825 -18,458 -24,436 33.86%
Tax -32 -36 0 -
NP -43,857 -18,422 -24,436 33.91%
Tax Rate - - - -
Total Cost 43,857 18,620 25,798 30.33%
Ratio Analysis
31/03/24 31/03/23 31/03/22 CAGR
NP Margin 0.00 -9,304.04 -1,794.13 -
Per Share
31/03/24 31/03/23 31/03/22 CAGR
EPS -1.20 -4.89 -9.26 -63.95%
EPS Diluted -1.20 -4.89 -9.26 -63.95%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.